TVARDI THERAPEUTICS, INC. (TVRD) Return on equity 2016–2022
TVARDI THERAPEUTICS, INC. (TVRD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-53.8%FY2022 · since FY2016: -112.9% → -53.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -53.8% | -15.0 pp |
| FY2021 | -38.9% | -42.2 pp |
| FY2020 | 3.4% | +60.3 pp |
| FY2019 | -57.0% | -1.6 pp |
| FY2018 | -55.4% | +11.6 pp |
| FY2017 | -67.0% | +45.9 pp |
| FY2016 | -112.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TVRD financial trends
TVRD RevenueTVRD Net incomeTVRD Net marginTVRD Gross profitTVRD Gross marginTVRD Operating incomeTVRD Operating marginTVRD Operating cash flowTVRD Free cash flowTVRD Capital expendituresTVRD Stock buybacksTVRD Dividends paidTVRD Total assetsTVRD Total liabilitiesTVRD Shareholders’ equityTVRD overview →